Google Ventures and US healthcare specialist Redmile were among a group of investors supporting a £35.5 million funding round for UK biotech Evox Therapeutics, which specialises in drugs de
The UK’s pharma trade body has, for the first time, set an investment target for the National Health Service, saying that it is key to secure the future of the life sciences industry as wel
After a slow first quarter, biotech IPOs may finally start to come into vogue in the coming months as a series of companies announced plans to go public.
After a disastrous winter where the NHS struggled to cope with demand, the Chancellor Philip Hammond has suggested that there will be no significant increase in funding in the next budget a
As the ASCO congress drew to a close, Johnson & Johnson filed for FDA approval of its BCMA-targeting CAR-T therapy Carvykti for use earlier in the treatment pathway fo
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas
